Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy
- PMID: 29922930
- DOI: 10.1007/s00330-018-5570-4
Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy
Abstract
Objectives: To assess whether extracellular volume (ECV) fraction with equilibrium contrast-enhanced multidetector computed tomography (MDCT) predicts outcomes for unresectable pancreatic adenocarcinoma patients treated with chemotherapy METHODS: Sixty-seven patients (42 men, 25 women; mean age, 67.5 years; range, 45-83 years) with histologically confirmed surgically unresectable pancreatic adenocarcinoma underwent contrast-enhanced MDCT before systemic chemotherapy. Tumour contrast enhancement (CE) and ECV fraction were calculated using region-of-interest measurement within the pancreatic adenocarcinoma and aorta on unenhanced and equilibrium phase-enhanced CT. The effect on survival variables including age, sex, tumour location, tumour size, TNM stage, carbohydrate antigen (CA) 19-9, carcinoembryonic antigen (CEA), tumour CE and tumour ECV fraction was determined on univariate and multivariate analyses using Cox proportional hazards regression model.
Results: Median overall survival was 10.5 months. On univariate analysis, elevated serum CA19-9 (hazard ratio (HR), 1.00; p = 0.006) and CEA (HR, 1.02; p = 0.011) levels were found to be associated with a negative effect on overall survival. Increasing tumour CE (HR, 0.98; p < 0.001) and ECV fraction (HR, 0.97; p = 0.001) were associated with a positive effect. Multivariate analysis revealed that only tumour ECV fraction was an independent predictor of overall survival (HR, 0.97; p = 0.012).
Conclusions: ECV fraction with equilibrium contrast-enhanced MDCT could be a useful imaging biomarker for predicting patient survival after chemotherapy for unresectable pancreatic adenocarcinoma.
Key points: • Tumour aggressiveness and response to therapy are influenced by the extravascular extracellular space. • Extracellular volume (ECV) fraction can be quantified with equilibrium contrast-enhanced CT. • Patients with higher tumour ECV fraction had better prognosis after chemotherapy.
Keywords: Contrast media; Extracellular space; Multidetector computed tomography; Pancreas cancer; Treatment outcome.
Similar articles
-
Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.Eur Radiol. 2020 Mar;30(3):1679-1689. doi: 10.1007/s00330-019-06517-w. Epub 2019 Nov 14. Eur Radiol. 2020. PMID: 31728691
-
Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms.Pancreatology. 2021 Jun;21(4):779-786. doi: 10.1016/j.pan.2021.02.020. Epub 2021 Mar 3. Pancreatology. 2021. PMID: 33714670
-
Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients.Eur J Radiol. 2025 Oct;191:112273. doi: 10.1016/j.ejrad.2025.112273. Epub 2025 Jun 27. Eur J Radiol. 2025. PMID: 40618544
-
Pancreatic adenocarcinoma.Eur Radiol. 2007 Mar;17(3):638-49. doi: 10.1007/s00330-006-0435-7. Epub 2006 Oct 5. Eur Radiol. 2007. PMID: 17021700 Review.
-
Multidetector computed tomography during combined therapy for pancreatic adenocarcinoma.Clin Gastroenterol Hepatol. 2008 Aug;6(8):842-848.e3. doi: 10.1016/j.cgh.2008.03.023. Epub 2008 Jun 27. Clin Gastroenterol Hepatol. 2008. PMID: 18585978 Review.
Cited by
-
Synthetic tumor extracellular volume as a predictive biomarker for colorectal liver metastasis patients prior to curative hepatectomy.Eur Radiol. 2025 Sep;35(9):5348-5359. doi: 10.1007/s00330-025-11503-6. Epub 2025 Mar 24. Eur Radiol. 2025. PMID: 40126606
-
Extracellular volume fraction derived from dual-energy CT: a potential predictor for acute pancreatitis after pancreatoduodenectomy.Eur Radiol. 2024 Nov;34(11):6957-6966. doi: 10.1007/s00330-024-10750-3. Epub 2024 May 17. Eur Radiol. 2024. PMID: 38760508
-
Dual energy CT-derived quantitative parameters and hematological characteristics predict pathological complete response in neoadjuvant chemoradiotherapy esophageal squamous cell carcinoma patients.BMC Gastroenterol. 2025 May 10;25(1):357. doi: 10.1186/s12876-025-03964-2. BMC Gastroenterol. 2025. PMID: 40349002 Free PMC article.
-
Association of CT-derived extracellular volume fraction combined with serological markers with histological grading of colorectal cancer.Medicine (Baltimore). 2025 Aug 15;104(33):e43502. doi: 10.1097/MD.0000000000043502. Medicine (Baltimore). 2025. PMID: 40826787 Free PMC article.
-
Extracellular volume fraction determined by equilibrium contrast-enhanced computed tomography: correlation with histopathological findings in gastric cancer.Jpn J Radiol. 2023 Jul;41(7):752-759. doi: 10.1007/s11604-023-01393-3. Epub 2023 Feb 3. Jpn J Radiol. 2023. PMID: 36735208 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical